Ethanol Extract of Licorice Alleviates HFD-Induced Liver Fat Accumulation in Association with Modulation of Gut Microbiota and Intestinal Metabolites in Obesity Mice

Nutrients. 2022 Oct 8;14(19):4180. doi: 10.3390/nu14194180.

Abstract

As a traditional Chinese medicine, licorice is often used in functional foods for its health benefits. However, the role of gut microbiota in the efficacy of licorice has not yet been fully elucidated. We hypothesized that the involvement of intestinal flora may be a key link in licorice ethanol extract (LEE)-induced health benefits. The aim of this study was to investigate whether LEE improves hepatic lipid accumulation in obese mice fed a high-fat diet (HFD) and whether the gut microbiota plays a key role in LEE treatment. Male C57BL/6J mice were fed HFD for liver fat accumulation and then treated with LEE. The same experiments were later performed using pseudo-sterile mice to verify the importance of gut flora. Supplementation with LEE improved the obesity profile, lipid profile and liver fat accumulation in HFD mice. In addition, LEE treatment improved intestinal flora dysbiosis caused by HFD in mice, as evidenced by a decrease in the percentage of Firmicutes/Bacteroidetes and an increase in the abundance of known anti-obesity-related bacteria. However, LEE failed to exhibit a therapeutic effect in pseudo-sterile mice. The results of the cellular assay showed that glycyrrhetic acid (GA), the main conversion product of glycyrrhizin (GL), was more effective in reducing fat accumulation and intracellular TG content in hepatocytes compared to GL. In conclusion, our data suggest that LEE attenuates obesity and hepatic fat accumulation in HFD mice, which may be associated with modulating the composition of gut microbiota and the conversion of LLE by the intestinal flora.

Keywords: ethanol extract; gut microbiota; hepatic lipid accumulation; high-fat diet; licorice; pseudo-germ-free.

MeSH terms

  • Animals
  • Diet, High-Fat / adverse effects
  • Dysbiosis / microbiology
  • Ethanol / pharmacology
  • Gastrointestinal Microbiome*
  • Glycyrrhetinic Acid* / pharmacology
  • Glycyrrhiza*
  • Glycyrrhizic Acid / pharmacology
  • Lipids / pharmacology
  • Liver / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Obese
  • Obesity / drug therapy
  • Obesity / etiology
  • Obesity / metabolism
  • Plant Extracts / therapeutic use

Substances

  • Lipids
  • Plant Extracts
  • Ethanol
  • Glycyrrhizic Acid
  • Glycyrrhetinic Acid